Sourasky Medical Center (Ichilov)
Sigmoid adenocarcinoma treatment cost in Israel typically involves diagnostics like a PET-CT scan running from $1,300 to $1,800 and primary surgical interventions. A colectomy (large bowel resection) costs between $20,500 and $33,500 depending on the complexity and surgical approach used. Total expenses are influenced by the cancer stage and hospital type, with international patients often seeing 30-80% savings compared to the US. Leading treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Sigmoid Adenocarcinoma Treatment Costs in Israel
Bookimed Expert Insight: For complex gastrointestinal oncology, Sourasky Medical Center (Ichilov) is ideal due to its 90% success rate. Patients seeking personalized care should consider Assuta Medical Center, the largest private clinic in Israel. Advanced surgical cases benefit from pioneers like Dr. Alon Pikarsky at Hadassah Medical Center. Multidisciplinary teams at these JCI-accredited centers ensure high safety standards for international patients.
| Izrael | Turcja | Austria | |
| Kolektomia (resekcja jelita grubego) | od $20,500 | od $6,912 | od $22,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Radioterapia raka odbytnicy | - | od $7,000 | od $12,000 |
Dyrektor instytutu nowotworów układu pokarmowego w Centrum Medycznym Sourasky – dr Sharon Peled specjalizuje się w leczeniu systemowym nowotworów przewodu pokarmowego.
Prof. Ofer Merimsky jest czołowym onkologiem w Centrum Medycznym Sourasky, specjalizującym się w nowotworach kości i tkanek miękkich. Jego kilkudziesięcioletnie doświadczenie obejmuje pełnienie funkcji kierowniczych w światowych towarzystwach onkologicznych.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Robotic and laparoscopic sigmoid colectomy for cancer are standard, widely available procedures in Israeli hospitals. JCI-accredited centers in Tel Aviv and Jerusalem utilize the Da Vinci system for precise tumor removal. These minimally invasive techniques are the preferred standard for treating sigmoid adenocarcinoma.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization where oncologists like Dr. Ofer Merimsky collaborate with surgical teams for complex cases. Large facilities like Sourasky and Assuta handle over 30,000 and 92,000 operations per year respectively. This high volume suggests that surgical teams maintain a high degree of proficiency in minimally invasive techniques.
Patient Consensus: Patients note that the small incisions lead to much less pain compared to traditional open surgery. They often express relief at how quickly they can walk and eat again after the procedure.
Bowel function restoration and early mobilization define the Israeli sigmoid colectomy recovery timeline. Patients usually stay in the hospital for 3 to 7 days. Full functional recovery typically occurs within 4 to 8 weeks. Specialized centers often employ Enhanced Recovery After Surgery protocols to speed healing.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report a 90% success rate in oncology treatments. This high performance is often linked to the extreme specialization of their surgeons. For example, Dr. Joseph Klauzner has over 45 years of experience in colorectal procedures. Choosing a facility with such established surgical leadership often ensures more predictable recovery milestones.
Patient Consensus: Patients emphasize that frequent walking is the best way to manage gas pain and restart digestion. Many note a significant wave of fatigue hitting 2 to 4 weeks after returning home.
Israeli medical centers like Sourasky, Assuta, and Hadassah maintain Joint Commission International accreditation for colon cancer care. These facilities prioritize multidisciplinary treatment for sigmoid adenocarcinoma. Patients access specialists trained at premier global institutions like the Royal Marsden and University of Toronto.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Hadassah manage immense patient volumes, exceeding 1,000,000 annual visits. This high frequency allows surgeons to refine techniques for complex sigmoid adenocarcinoma cases. Clinics like Assuta offer private-sector flexibility. This lets patients select specific senior surgeons for robotic-assisted colectomy procedures.
Patient Consensus: Patients note the seamless coordination during diagnostics, often completing biopsies and PET/CT scans within days. Many feel reassured by doctors who explain surgical steps in clear, empathetic English.
Most patients undergoing sigmoid cancer surgery in Israel do not require a permanent stoma. Israeli surgeons prioritize primary anastomosis to reconnect the healthy bowel directly. A temporary stoma may be used for 6 to 12 weeks to protect the new connection while it heals properly.
Bookimed Expert Insight: Israeli oncology centers like Sourasky perform over 34,000 operations annually with a 90% success rate. High-volume centers often utilize Enhanced Recovery After Surgery (ERAS) protocols. These protocols help patients achieve primary anastomosis without needing a defunctioning stoma by prioritizing pre-operative preparation. Choosing a surgeon with over 20 years of experience, such as Dr. Gideon Goldman, further improves outcomes.
Patient Consensus: Patients note that temporary stomas are often part of the healing process to prevent leaks. They emphasize that minimally invasive surgery made their recovery faster and helped them avoid a permanent stoma.
Potential complications from sigmoid colectomy include anastomotic leaks, surgical site infections, and ileus. Israeli hospitals manage these risks through Enhanced Recovery After Surgery protocols. Highly trained teams at Joint Commission International-accredited facilities use laparoscopic and robotic techniques to minimize postoperative trauma and improve outcomes.
Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center report high success rates by combining surgical expertise with multidisciplinary oversight. Senior surgeons like Dr. Ron Greenberg and Dr. Joseph Klauzner specialize in minimally invasive colorectal procedures. This focus on laparoscopy significantly lowers the frequency of wound infections compared to traditional open surgery.
Patient Consensus: Patients emphasize the importance of walking soon after surgery to restart bowel function. Many recommend asking for stool tests if diarrhea occurs to rule out infections during recovery.
Israeli oncology centers perform staging work-up within 1 to 2 days of arrival. Diagnostic protocols include PET-CT, chest and abdominal CT, and CEA bloodwork. Surgery for sigmoid adenocarcinoma is usually scheduled within 7 to 14 days once the multidisciplinary tumor board approves the treatment plan.
Bookimed Expert Insight: While many believe surgery is the immediate step, Israeli centers like Sourasky Medical Center emphasize a multidisciplinary tumor board review first. Data shows these boards, featuring experts like Dr. Ron Greenberg and Dr. Ido Wolf, often refine the surgical approach. This can range from robotic-assisted resections to combining surgery with HIPEC for advanced cases, which significantly impacts long-term success rates.
Patient Consensus: Patients note it is vital to bring original pathology slides and digital imaging to avoid redundant diagnostic steps. Preparing these materials beforehand often helps secure an operation date within the first week of arrival.
Patients should plan for a 10 to 14 day stay in Israel for sigmoid cancer surgery. This timeframe includes 3 to 7 days of hospitalization and one week of local recovery. Most centers clear patients for international travel approximately 10 days after the procedure.
Bookimed Expert Insight: While basic recovery takes 14 days, choosing centers like Sourasky or Assuta often allows for robotic-assisted surgery. Data shows these clinics handle over 30,000 operations annually. This high volume typically correlates with more efficient discharge protocols and faster returns of bowel function.
Patient Consensus: Patients note it is critical to stay nearby for the first 2 weeks. They emphasize building flexibility into travel plans in case pathology results or wound healing require extra time.